Potent Inhibition of SARS-CoV-2 nsp14 N 7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues - Archive ouverte HAL
Journal Articles Journal of Medicinal Chemistry Year : 2022

Potent Inhibition of SARS-CoV-2 nsp14 N 7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues

Abstract

Enzymes involved in RNA capping of SARS-CoV-2 are essential for the stability of viral RNA, translation of mRNAs, and virus evasion from innate immunity, making them attractive targets for antiviral agents. In this work, we focused on the design and synthesis of nucleoside-derived inhibitors against the SARS-CoV-2 nsp14 (N7-guanine)-methyltransferase (N7-MTase) that catalyzes the transfer of the methyl group from the S-adenosyl-L-methionine (SAM) cofactor to the N7-guanosine cap. Seven compounds out of 39 SAM analogues showed remarkable double-digit nanomolar inhibitory activity against the N7-MTase nsp14. Molecular docking supported the structure−activity relationships of these inhibitors and a bisubstrate-based mechanism of action. The three most potent inhibitors significantly stabilized nsp14 (ΔT m ≈ 11 °C), and the best inhibitor demonstrated high selectivity for nsp14 over human RNA N7-MTase.
Fichier principal
Vignette du fichier
jmedchem Rostom 2022.pdf (5.3 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-03721688 , version 1 (12-07-2022)

Identifiers

Cite

Rostom Ahmed‐belkacem, Marcel Hausdorff, Adrien Delpal, Priscila Sutto-Ortiz, Agathe M G Colmant, et al.. Potent Inhibition of SARS-CoV-2 nsp14 N 7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues. Journal of Medicinal Chemistry, 2022, 65 (8), pp.6231-6249. ⟨10.1021/acs.jmedchem.2c00120⟩. ⟨hal-03721688⟩
124 View
219 Download

Altmetric

Share

More